Welcome

United States Antiarthritis Market

 

  • Research Code : 5828-01-00-00-00
  • SKU : HC00276-NA-MR_03291
  • Share this :
  • Release Date : 12-Dec-2000
  • Region : North America
  • Request Study Sample

Availability: In stock

 
USD 3,950

* Required Fields

Pay By Invoice

Be the first to review this product



Table of Contents

United States Antiarthritis Market, Executive Summary

Introduction to the U.S. Prescription Arthritis Market

Introduction to the U.S. Prescription Arthritis Market

Objectives and Purpose

Objectives and Purpose

Report Scope and Segmentation

Report Scope and Segmentation

Report Structure

Report Structure

Current Treatments

Current Treatments

Current Drug Therapies

Current Drug Therapies

Prevalence of Arthritis in the United States

Prevalence of Arthritis in the United States

Summary of Major Findings

Market Growth, Opportunities, and Total Forecast
Competitive Analysis

Strategies for Success

Strategies for Success

United States Antiarthritis Market, Market Engineering Research Methodology

Research Scope

Objectives and Purpose
Report Structure and Market Segmentation

Market Engineering Forecasting Methodology

Overview
Strategic Significance of the Market Engineering Forecast
Judging Credibility and Accuracy of Market Engineering Forecasts
Forecast Assumptions

Glossary of Terms

List of Definitions
List of Acronyms

United States Antiarthritis Market, Industry Challenges

Identification of Challenges Facing the Antiarthritis Drug Market

Identification of Challenges Facing the Antiarthritis Drug Market
Dearth of Awareness Curtails Number of Treated Patients
Lack of An Efficacious and Safe Drug Diminishes Market Revenues
Towering Direct-To-Consumer Advertising Costs Limits Profitability
Sustaining the Cut Throat Competition Abates Promotion
The Myth That Arthritis is an Untreatable Elderly Disease Confines Market Growth
Paucity of Physician Education Impedes Market Penetration
Generic Competition Reins Prescriptions
Reimbursement Issues With Managed Care Retards Expansion
Low Treatment Cost Therapies Downcast Revenues
Over-The-Counter Medications Consume Prescription Sales

Market Engineering Research for the Total U.S. Antiarthritis Market 1996-2006

Market Overview

Market Overview
Disease Overview
Scope and Segmentation
History

Market Engineering Research Measurement System

Market Engineering Research Measurement System

Market Drivers

Market Drivers

Market Restraints

Market Restraints

Market Engineering Revenue Forecasts (1996-2006)

Demand Analysis
Pricing Analysis
Revenues

Competitive Analysis

Competitive Structure
Competitive Factors
Market Share Analysis
Market Share Winners and Why
Market Share Losers and Why

Product Analysis

Products in the Market
Products in Clinical Trials
Products failures

Market Engineering Research for the U.S. Prescription Non-Steroidal Anti-Inflammatory Market 1996-2006

Total Market Segment Analysis

Market Overview
Definition
Market Engineering Research Measurement System
Market Engineering Unit and Revenue Forecasts (1996-2006)
Pricing Strategy and Trend Analysis
Competitive Structure

Market Engineering Research for the U.S. Disease Modifying Anti-Rheumatic Drugs Market 1996-2006

Total Market Segment Analysis

Market Overview
Definition
Scope and Segmentation
Market Engineering Research Measurement System
Market Engineering Unit and Revenue Forecasts (1999-2006)
Pricing Strategy and Trend Analysis
Competitive Structure

Market Engineering Research for the U.S. Biological Response Modifiers Market 1996-2006

Total Market Segment Analysis

Market Overview
Definition
Market Engineering Research Measurement System
Market Engineering Unit and Revenue Forecasts (1995-2005)
Pricing Strategy and Trend Analysis
Competitive Structure
Abgenix
Alexion Pharmaceutical Inc.
Amgen
Angiotech Pharmaceuticals, Inc.
AutoImmune
Axys Pharmaceutical
Biogen
Boston Life Sciences, Inc.
Cambridge Antibody Technology Group plc
Celgene Inc.
CellTech Group
Centocor Inc.
Connetics Corporation
Corixa Inc.
Genetics Institute Inc.
IDEC Pharmaceuticals
Immune Response Corp.
Immunex Inc.
Inflazyme Pharmaceuticals Ltd.
Isis Pharmaceuticals, Inc.
Medarex, Inc.
SuperGen Inc.
Valentis Inc.
Vertex Pharmaceuticals Inc.

United States Antiarthritis Market, Market Engineering Strategy

Measurement-Driven Strategy Generation

Market Engineering Challenges Versus Departmental Responsibility
Market Drivers Versus Departmental Responsibility
Market Restraints Versus Departmental Responsibility
Market Engineering Measurement Trends Versus Departmental Responsibility
Market Engineering Strategic Recommendations

Market Engineering Awards for the U.S. Antiarthritis Drugs Market

Frost & Sullivan's 2000 Market Engineering Awards

Frost & Sullivan's 2000 Market Engineering Awards

Market Engineering Awards

Market Engineering Awards
Award Category: Brand Awareness Development
Award Category: Market Engineering Leadership – Antiarthritis Drugs Market
Award Category: Market Engineering Leadership – DMARDs Market
Award Category: Product Innovation
Award Category: Product Launch Strategy


Sample Study






Related Research
WHY CHOOSE
FROST & SULLIVAN
RESEARCH ?

1. Primary Research

Our analysis is based on comprehensive primary research conducted with core market participants.

2. Global Coverage

Unparalleled coverage of geographies, our analyst & consultant teams are based in 42+ offices spanning the globe.

3. Breadth of Vertical Industries

We cover the broadest spectrum of markets to provide our clients with the most relevant analysis and transformational insights.

4. Visionary Innovation Research

With on-going transformational shifts, our visionary innovation research prepares you with information on key megatrends shaping the future of your industry.

5. Mega Trends

Mega Trends are global forces that transform business, societies and economies.

6. Convergence Research Coverage

Taking an approach of analysing a macro-to-micro impact, our convergence research helps you prepare against an impending 'Kodak moment'.